Andrea Abbott

Concepts (208)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
12
2021
1536
1.760
Why?
Melanoma
5
2020
335
1.410
Why?
Carcinoma, Intraductal, Noninfiltrating
4
2021
33
1.360
Why?
Skin Neoplasms
5
2020
375
1.360
Why?
Mastectomy, Segmental
8
2021
64
1.290
Why?
Carcinoma, Ductal, Breast
5
2021
62
1.160
Why?
Liver Neoplasms
3
2018
334
1.160
Why?
Yttrium Radioisotopes
2
2018
4
1.140
Why?
Embolization, Therapeutic
2
2018
150
0.970
Why?
Surgical Procedures, Operative
1
2021
124
0.740
Why?
Workplace
1
2020
75
0.700
Why?
Neoplasm Recurrence, Local
4
2016
446
0.700
Why?
Burnout, Professional
1
2020
64
0.680
Why?
Intraoperative Care
3
2016
91
0.660
Why?
Drug Prescriptions
1
2020
135
0.660
Why?
Uveal Neoplasms
1
2018
16
0.630
Why?
Internship and Residency
2
2022
596
0.620
Why?
Pain, Postoperative
1
2020
214
0.620
Why?
Pandemics
1
2021
352
0.610
Why?
Mastectomy
2
2021
57
0.590
Why?
Lymph Node Excision
3
2017
91
0.570
Why?
Physicians
1
2020
324
0.560
Why?
Prognosis
9
2021
2093
0.560
Why?
Health Promotion
1
2020
407
0.550
Why?
Opioid-Related Disorders
1
2020
298
0.540
Why?
Middle Aged
23
2021
21147
0.510
Why?
Aged
21
2021
14862
0.510
Why?
Aged, 80 and over
11
2021
4848
0.500
Why?
Retrospective Studies
16
2021
7277
0.500
Why?
Analgesics, Opioid
1
2020
498
0.500
Why?
Radiotherapy
2
2016
86
0.500
Why?
Length of Stay
5
2017
780
0.480
Why?
Carcinoma
1
2015
215
0.450
Why?
Brachytherapy
1
2013
79
0.440
Why?
Colorectal Neoplasms
2
2016
561
0.430
Why?
Female
25
2021
38074
0.430
Why?
Electrocoagulation
1
2012
35
0.410
Why?
Surgical Wound Infection
2
2017
168
0.400
Why?
Retroperitoneal Neoplasms
1
2012
12
0.400
Why?
Anus Neoplasms
1
2012
37
0.400
Why?
Mammaplasty
1
2012
41
0.390
Why?
Sarcoma
1
2012
70
0.390
Why?
Anesthetics, Local
1
2012
83
0.390
Why?
Humans
28
2022
68618
0.370
Why?
Hospital Mortality
1
2012
384
0.360
Why?
Colonic Neoplasms
1
2012
299
0.350
Why?
Postoperative Complications
3
2017
1615
0.330
Why?
Age Factors
4
2021
1864
0.330
Why?
Adult
14
2021
21403
0.320
Why?
Neoplasm Staging
5
2018
800
0.280
Why?
Perception
2
2020
189
0.280
Why?
Robotic Surgical Procedures
2
2017
49
0.260
Why?
Survival Rate
3
2018
1056
0.250
Why?
Tertiary Care Centers
2
2021
67
0.230
Why?
Neoplasm, Residual
2
2021
33
0.230
Why?
Adenocarcinoma
2
2017
475
0.220
Why?
Male
13
2021
37321
0.220
Why?
Lymphatic Metastasis
2
2020
274
0.200
Why?
Perioperative Period
1
2021
24
0.200
Why?
Young Adult
4
2021
5717
0.200
Why?
Clinical Clerkship
1
2022
63
0.200
Why?
Sentinel Lymph Node Biopsy
3
2020
53
0.190
Why?
Elective Surgical Procedures
1
2021
95
0.190
Why?
Treatment Outcome
5
2018
7029
0.190
Why?
Time-to-Treatment
1
2021
117
0.190
Why?
Waste Management
1
2020
11
0.180
Why?
Follow-Up Studies
3
2018
3259
0.180
Why?
Mitosis
1
2020
76
0.180
Why?
Students, Medical
1
2022
210
0.180
Why?
Operative Time
3
2017
45
0.170
Why?
General Surgery
1
2020
95
0.170
Why?
Reoperation
1
2021
467
0.170
Why?
Carcinoma, Lobular
2
2016
20
0.170
Why?
Patient Satisfaction
1
2021
378
0.160
Why?
Time Factors
4
2015
4655
0.160
Why?
Anxiety
1
2021
422
0.160
Why?
Radiotherapy, Adjuvant
2
2016
125
0.160
Why?
Feasibility Studies
1
2020
652
0.160
Why?
Receptors, Estrogen
1
2018
142
0.150
Why?
Glycation End Products, Advanced
1
2018
125
0.150
Why?
Patient Education as Topic
1
2020
425
0.150
Why?
Lymph Nodes
2
2017
258
0.150
Why?
Radiotherapy Dosage
2
2016
125
0.140
Why?
Skin
1
2020
451
0.140
Why?
Esophagectomy
1
2017
26
0.140
Why?
Glucose Transporter Type 1
1
2016
18
0.140
Why?
DNA Polymerase II
1
2016
5
0.140
Why?
F-Box Proteins
1
2016
14
0.140
Why?
Quality Improvement
1
2020
413
0.140
Why?
Life Style
1
2018
338
0.140
Why?
Proportional Hazards Models
2
2016
792
0.140
Why?
SEER Program
2
2020
153
0.130
Why?
Esophageal Neoplasms
1
2017
150
0.130
Why?
Ubiquitin-Protein Ligases
1
2016
89
0.130
Why?
Surveys and Questionnaires
2
2021
2800
0.130
Why?
Patient Selection
2
2016
592
0.130
Why?
Axilla
1
2015
36
0.130
Why?
Choristoma
1
2015
20
0.130
Why?
Rose Bengal
1
2014
3
0.120
Why?
Chemotherapy, Cancer, Regional Perfusion
1
2014
2
0.120
Why?
Disease Progression
1
2018
1038
0.120
Why?
BCG Vaccine
1
2014
12
0.120
Why?
Injections, Intralesional
1
2014
25
0.120
Why?
United States
4
2022
7367
0.120
Why?
Adjuvants, Immunologic
1
2014
63
0.120
Why?
Survival Analysis
2
2016
714
0.120
Why?
Cell Cycle Proteins
1
2016
230
0.120
Why?
Antineoplastic Agents, Alkylating
1
2014
57
0.120
Why?
Breast
1
2015
137
0.120
Why?
Patient Readmission
2
2017
267
0.120
Why?
Iridium Radioisotopes
1
2013
11
0.120
Why?
Interleukin-2
1
2014
133
0.110
Why?
Immunologic Factors
1
2014
87
0.110
Why?
Laparoscopy
1
2016
237
0.110
Why?
Multivariate Analysis
2
2016
1046
0.110
Why?
Quality of Life
1
2021
1515
0.110
Why?
Neoplasms, Second Primary
1
2013
62
0.110
Why?
Adolescent
4
2020
8912
0.110
Why?
Pancreatic Neoplasms
1
2016
332
0.110
Why?
Inguinal Canal
1
2012
5
0.110
Why?
Surgical Wound Dehiscence
1
2012
20
0.100
Why?
Genetic Therapy
1
2014
291
0.100
Why?
Hepatectomy
1
2012
58
0.100
Why?
Gene Expression Regulation, Neoplastic
1
2016
756
0.100
Why?
Confidence Intervals
1
2012
242
0.100
Why?
Practice Patterns, Physicians'
1
2016
504
0.100
Why?
Colectomy
1
2012
64
0.100
Why?
Lidocaine
1
2012
36
0.100
Why?
Camping
1
2011
6
0.100
Why?
Minimally Invasive Surgical Procedures
1
2012
85
0.100
Why?
Epinephrine
1
2012
103
0.100
Why?
Fires
1
2011
21
0.100
Why?
Statistics, Nonparametric
1
2012
306
0.100
Why?
Bronchodilator Agents
1
2012
43
0.100
Why?
Cohort Studies
3
2016
2358
0.100
Why?
Carcinoma, Squamous Cell
1
2017
629
0.100
Why?
Prospective Studies
3
2015
3705
0.100
Why?
Chi-Square Distribution
1
2012
546
0.090
Why?
Surgical Flaps
1
2012
120
0.090
Why?
Neoplasm Invasiveness
1
2012
369
0.090
Why?
Peritoneal Neoplasms
1
2010
23
0.090
Why?
Mesothelioma
1
2010
21
0.090
Why?
Burns
1
2011
83
0.090
Why?
Gastrointestinal Neoplasms
1
2010
40
0.090
Why?
Water-Electrolyte Imbalance
1
2010
29
0.090
Why?
Odds Ratio
1
2012
880
0.090
Why?
Hyperthermia, Induced
1
2010
53
0.090
Why?
Obesity
1
2017
1076
0.080
Why?
Preoperative Care
1
2011
275
0.080
Why?
Sentinel Lymph Node
2
2020
4
0.080
Why?
Pediatrics
1
2011
341
0.080
Why?
Sex Factors
1
2012
1266
0.080
Why?
Antineoplastic Agents
1
2015
1070
0.070
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2010
468
0.070
Why?
Risk Factors
2
2018
5731
0.070
Why?
Tumor Burden
2
2017
132
0.070
Why?
Combined Modality Therapy
2
2018
951
0.050
Why?
Magnetic Resonance Imaging
1
2011
2223
0.050
Why?
Risk Assessment
2
2020
2007
0.050
Why?
Schools, Medical
1
2022
157
0.050
Why?
Educational Measurement
1
2022
254
0.050
Why?
Kaplan-Meier Estimate
1
2020
536
0.040
Why?
Neoplasm Grading
1
2018
111
0.040
Why?
Tamoxifen
1
2018
62
0.040
Why?
Antineoplastic Agents, Hormonal
1
2018
99
0.040
Why?
Anastomotic Leak
1
2017
11
0.040
Why?
Hospitals, High-Volume
1
2017
18
0.040
Why?
Learning Curve
1
2016
20
0.040
Why?
F-Box-WD Repeat-Containing Protein 7
1
2016
1
0.030
Why?
Poly-ADP-Ribose Binding Proteins
1
2016
7
0.030
Why?
Equipment Failure
1
2016
112
0.030
Why?
Blood Loss, Surgical
1
2017
79
0.030
Why?
Cancer Survivors
1
2018
146
0.030
Why?
Drug Resistance, Neoplasm
1
2018
332
0.030
Why?
Florida
1
2016
221
0.030
Why?
Fluorodeoxyglucose F18
1
2016
81
0.030
Why?
Medical Errors
1
2016
80
0.030
Why?
Pelvis
1
2016
38
0.030
Why?
Pneumonia
1
2017
110
0.030
Why?
Venous Thrombosis
1
2017
125
0.030
Why?
Canada
1
2016
267
0.030
Why?
Positron-Emission Tomography
1
2016
160
0.030
Why?
Disease-Free Survival
1
2016
349
0.030
Why?
Prophylactic Surgical Procedures
1
2015
2
0.030
Why?
Overweight
1
2017
186
0.030
Why?
Preoperative Period
1
2015
50
0.030
Why?
Postoperative Period
1
2015
238
0.030
Why?
Pulmonary Embolism
1
2017
253
0.030
Why?
Cell Line, Tumor
1
2018
1851
0.030
Why?
Body Mass Index
1
2017
867
0.030
Why?
Biomarkers
1
2018
1593
0.030
Why?
Registries
1
2016
733
0.030
Why?
Comorbidity
1
2017
1426
0.030
Why?
RNA, Messenger
1
2016
1664
0.030
Why?
Incidence
1
2016
1603
0.030
Why?
Longitudinal Studies
1
2015
1054
0.020
Why?
Health Status Indicators
1
2011
117
0.020
Why?
Mutation
1
2016
1213
0.020
Why?
Organoplatinum Compounds
1
2010
21
0.020
Why?
Mitomycin
1
2010
27
0.020
Why?
Clinical Trials, Phase I as Topic
1
2010
26
0.020
Why?
Clinical Trials, Phase II as Topic
1
2010
58
0.020
Why?
Cardiovascular Diseases
1
2017
940
0.020
Why?
Signal Transduction
1
2018
2689
0.020
Why?
Hospitalization
1
2011
978
0.020
Why?
Infant
1
2011
2891
0.020
Why?
Child, Preschool
1
2011
3187
0.020
Why?
Child
1
2011
6405
0.010
Why?
Abbott's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (208)
Explore
_
Co-Authors (19)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_